![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vol. 304, Issue 3, 985-993, March 2003
Cardiac Medicine, National Heart and Lung Institute, Imperial
College London, United Kingdom (R.L., P.C., K.T.M.); and Wake Forest
University School of Medicine, Winston-Salem, North Carolina (J.K.W.)
Soy-derived isoflavones appear to possess cardioprotective properties,
although the precise nature of this protection and the particular
isoflavones responsible remain unclear. We hypothesized that
isoflavones may differ in their cardiac actions in view of their
varying affinities for the estrogen receptor and differences in ability
to inhibit tyrosine kinase. We investigated the direct effects of three
closely related isoflavones, genistein, daidzein, and equol (a
metabolite of daidzein formed by gut microflora), on the contractile
function of isolated guinea pig ventricular myocytes. Genistein (10 and
40 µM) significantly increased cell shortening and the
Ca2+ transient (measured using indo-1). In contrast,
equivalent concentrations of equol produced the opposite effect,
decreasing cell shortening and the Ca2+ transient, whereas
daidzein was without effect. The opposing actions of genistein and
equol were still observed in the presence of the specific estrogen
receptor antagonist ICI 182,780 (10 µM). However, the stimulatory
actions of genistein were markedly reduced in the presence of the
potent phosphotyrosine phosphatase inhibitor, bpV(phen). Both genistein
and equol significantly inhibited the peak L-type Ca2+
current. We conclude that genistein and equol affect the contractile function of ventricular myocytes in opposing ways despite a common initial action of Ca2+ current antagonism. These
differences occur independently of the estrogen receptor but may be
partly related to the unique actions of genistein as a tyrosine kinase
inhibitor. Furthermore, isoflavone metabolites, such as equol, may be
more biologically active than their precursors and have a greater role
in cardioprotection than previously realized.
This article has been cited by other articles:
![]() |
N. D. Ullrich, A. Krust, P. Collins, and K. T. MacLeod Genomic deletion of estrogen receptors ER{alpha} and ER{beta} does not alter estrogen-mediated inhibition of Ca2+ influx and contraction in murine cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2421 - H2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Souzeau, S. Belanger, S. Picard, and C. F. Deschepper Dietary isoflavones during pregnancy and lactation provide cardioprotection to offspring rats in adulthood Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H715 - H721. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Atkinson, C. L. Frankenfeld, and J. W. Lampe Gut Bacterial Metabolism of the Soy Isoflavone Daidzein: Exploring the Relevance to Human Health Experimental Biology and Medicine, March 1, 2005; 230(3): 155 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Basu, S. Kubota, M. R. Meselhy, M. Ciotti, B. Chowdhury, M. Hartori, and I. S. Owens Gastrointestinally Distributed UDP-glucuronosyltransferase 1A10, Which Metabolizes Estrogens and Nonsteroidal Anti-inflammatory Drugs, Depends upon Phosphorylation J. Biol. Chem., July 2, 2004; 279(27): 28320 - 28329. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liew, M. A Stagg, J. Chan, P. Collins, and K. T MacLeod Gender determines the acute actions of genistein on intracellular calcium regulation in the guinea-pig heart Cardiovasc Res, January 1, 2004; 61(1): 66 - 76. [Abstract] [Full Text] [PDF] |
||||